Adicet Bio Inc ACET:NASDAQ

Last Price$14.30NASDAQ Closing Price as of 4:00PM ET 8/19/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change-0.39(2.65%)
Bid (Size)$13.80 (5)
Ask (Size)$15.39 (3)
Day Low / High$13.86 - 14.50
Volume368.0 K

Read more news Recent News

Adicet Bio's Q2 Net Loss Widens
7:40AM ET 8/10/2022 MT Newswires

Adicet Bio (ACET) reported Q2 net loss Wednesday of $0.56 per diluted share, widening from a loss of $0.34 a year earlier. Analysts polled by Capital IQ...

Insider Sell: Adicet Bio
4:56PM ET 8/03/2022 MT Newswires

Blake Aftab, Chief Scientific Officer, on August 01, 2022, sold 6,968 shares in Adicet Bio (ACET) for $115,948. Following the Form 4 filing with the SEC,...

Adicet Bio Says FDA Grants Fast Track Designation for ADI-001 for Non-Hodgkin's Lymphoma
7:52AM ET 4/19/2022 MT Newswires

Adicet Bio (ACET) said Tuesday the US Food and Drug Administration has granted fast track designation to ADI-001, a CD20-targeted experimental medicine for...

SMBC Nikko Starts Adicet Bio at Outperform With $28 Price Target
1:41AM ET 3/31/2022 MT Newswires

Adicet Bio (ACET) has an average rating of buy and price targets ranging from $21 to $35, according to analysts polled by Capital IQ. (MT Newswires covers...

View all Commentary and Analysis

Adicet Bio, (ACET) Investor Presentation - Slideshow
11:48AM ET 8/12/2022 Seeking Alpha

Adicet Bio: A First Take
12:05PM ET 7/22/2022 Seeking Alpha

Adicet Bio (ACET) Investor Presentation - Slideshow
8:42AM ET 7/01/2022 Seeking Alpha

Healthcare Sector Stock Performance Continues To Improve
7:15AM ET 6/30/2022 Seeking Alpha

Company Profile

Business DescriptionAdicet Bio, Inc. is a biotechnology company, which engages in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA. View company web site for more details
Address200 Berkeley Street
Boston, Massachusetts 02116
Number of EmployeesN/A
Recent SEC Filing08/11/2022SC 13D/A
President, CEO, Secretary & DirectorChen Schor
Chief Financial OfficerBrian Nicholas Harvey
Chief Medical Officer & Senior Vice PresidentFrancesco Galimi
Chief Technology OfficerDonald Healey

Company Highlights

Price Open$14.38
Previous Close$14.69
52 Week Range$6.25 - 21.17
Market Capitalization$572.4 M
Shares Outstanding40.0 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement11/09/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.37
Beta vs. S&P 500N/A
Net Profit Margin-140.90%
Return on Equity-16.98%

Analyst Ratings as of 04/07/2022

Consensus RecommendationConsensus Icon
Powered by Factset